F Enright Selected Research

hecate-betaLH

7/2001

Targeted destruction of prostate cancer cells and xenografts by lytic peptide-betaLH conjugates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

F Enright Research Topics

Disease

1	Lymphadenopathy 07/2021
1	Splenomegaly 07/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2016
1	Chickenpox 05/2006
1	Necrosis 07/2001
1	Neoplasms (Cancer) 07/2001
1	Prostatic Neoplasms (Prostate Cancer) 07/2001
1	Body Weight (Weight, Body) 07/2001

Drug/Important Bio-Agent (IBA)

1	Anti-Bacterial Agents (Antibiotics)IBA 07/2021
1	Infliximab (Remicade)FDA Link 11/2016
1	Peptides (Polypeptides)IBA 07/2001
1	Estradiol (Delestrogen)FDA LinkGeneric 07/2001
1	Phor14-betaLHIBA 07/2001
1	Amino Acids FDA Link 07/2001
1	AndrogensIBA 07/2001
1	hecate-betaLHIBA 07/2001
1	Follicle Stimulating Hormone (Follitropin)FDA Link 07/2001

Therapy/Procedure

1	Therapeutics 05/2006